Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
602
datasets available to search
ShareScore release 0.9.0
Dataset results
602 results for “natural killer cell”
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00625729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06321484. IPD Sharing: YES. Countries: 1. Publications: 0.
UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT01313897. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
ClinicalTrials.gov study NCT00354172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
ClinicalTrials.gov study NCT07011004. IPD Sharing: YES. Countries: 1. Publications: 0.
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
ClinicalTrials.gov study NCT00416351. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00303667. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
ClinicalTrials.gov study NCT00698009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00652899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies
ClinicalTrials.gov study NCT00536978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological Malignancies
ClinicalTrials.gov study NCT06508489. IPD Sharing: YES. Countries: 2. Publications: 0.
Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood
ClinicalTrials.gov study NCT00450983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
ClinicalTrials.gov study NCT00871689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic T
ClinicalTrials.gov study NCT01621477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patie
ClinicalTrials.gov study NCT00789776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer
ClinicalTrials.gov study NCT00376805. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
ClinicalTrials.gov study NCT06318871. IPD Sharing: YES. Countries: 1. Publications: 0.
Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00526292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
ClinicalTrials.gov study NCT01390402. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
ClinicalTrials.gov study NCT00145626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.